BE0211-1MG
| InVivoMAb anti-human CD1a
| 1 mg
| BioXCell
| in vitro CD1a blockade, Flow cytometry
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0192-5MG
| InVivoMAb anti-human CD11a (LFA-1?)
| 5 mg
| BioXCell
| Functional assays, Flow cytometry
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0283-25MG
| InVivoMAb anti-mouse/human/rat CD47 (IAP)
| 25 mg
| BioXCell
| in vivo CD47 blockade, in vitro CD47 blocking, Imm
|
| Mouse
| Human, Mouse, Rat
| Solicitar Precio
| Solicitar
|
BE0256-100MG
| InVivoMAb anti-mouse IL-1 R (CD121a)
| 100 mg
| BioXCell
| in vivo IL-1 R blockade, in vitro IL-1 R blockade
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
BE0260-100MG
| InVivoMAb Armenian hamster IgG isotype control, anti-glutathione S-transferase
| 100 mg
| BioXCell
|
|
| Armenian Hamster
|
| Solicitar Precio
| Solicitar
|
BE0200-50MG
| InVivoMAb anti-mouse Pan-endothelial Cell Antigen (MECA-32)
| 50 mg
| BioXCell
| Immunohistochemistry (frozen), Flow cytometry, Wes
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0196-25MG
| InVivoMAb anti-mouse BTLA (CD272)
| 25 mg
| BioXCell
| in vivo BTLA blockade, in vitro T cell stimulation
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
BE0238-50MG
| InVivoMAb anti-human c-myc
| 50 mg
| BioXCell
| Western blot, ELISA, Immunoprecipitation, Flow cyt
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
BE0278-50MG
| InVivoMAb anti-human EGFR
| 50 mg
| BioXCell
| in vitro EGFR blockade, in vivo EGFR blockade in x
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0228-100MG
| InVivoMAb anti-mouse MHC Class I (H-2Kk, H-2Dk)
| 100 mg
| BioXCell
| Functional assays, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
BE0288-5MG
| InVivoMAb anti-human CD4
| 5 mg
| BioXCell
| in vitro CD4 blockade, in vitro blocking of CD4+ T
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0292-50MG
| InVivoMAb anti-human/monkey CD40L (CD154)
| 50 mg
| BioXCell
| in vitro blocking of CD40/CD40L signaling, in vivo
|
| Mouse
| Human, Monkey
| Solicitar Precio
| Solicitar
|
BE0281-1MG
| InVivoMAb anti-human CD19
| 1 mg
| BioXCell
| Flow cytometry, Functional assays, Immunofluoresce
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0213-100MG
| InVivoMAb anti-mouse CSF1R (CD115)
| 100 mg
| BioXCell
| in vivo macrophage depletion, in vitro CSF1R neutr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0191-100MG
| InVivoMAb anti-mouse RANKL (CD254)
| 100 mg
| BioXCell
| in vivo RANKL blockade
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0249-100MG
| InVivoMAb anti-mouse CXCR3 (CD183)
| 100 mg
| BioXCell
| in vivo CXCR3 neutralization, Flow cytometry
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
BE0198-25MG
| InVivoMAb anti-mouse/human IL-5
| 25 mg
| BioXCell
| in vivo IL-5 neutralization, in vivo eosinophil de
|
| Rat
| Human, Mouse
| Solicitar Precio
| Solicitar
|
BE0272-5MG
| InVivoMAb anti-mouse CD122 (IL-2R?)
| 5 mg
| BioXCell
| in vitro NK cell negative selection, Immunoprecipi
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0210-100MG
| InVivoMAb anti-mouse BTLA (CD272)
| 100 mg
| BioXCell
| Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
BE0214-25MG
| InVivoMAb anti-mouse Thy1.1 (CD90.1)
| 25 mg
| BioXCell
| in vivo T cell depletion
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
BE0199-25MG
| InVivoMAb anti-mouse IL-4
| 25 mg
| BioXCell
| ELISA, ELISPOT, Flow cytometry
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0235-25MG
| InVivoMAb anti-human IFN?
| 25 mg
| BioXCell
| in vivo IFN? neutralization in humanized mice, in
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0203-50MG
| InVivoMAb anti-mouse Ly6C
| 50 mg
| BioXCell
| in vivo macrophage depletion (in combination with
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0239-25MG
| InVivoMAb anti-mouse 4-1BB (CD137)
| 25 mg
| BioXCell
| in vivo 4-1BB stimulation, in vitro 4-1BB stimulat
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0270-50MG
| InVivoMAb anti-mouse CD47 (IAP)
| 50 mg
| BioXCell
| in vivo CD47 blockade, in vitro CD47 blockade, Imm
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0228-5MG
| InVivoMAb anti-mouse MHC Class I (H-2Kk, H-2Dk)
| 5 mg
| BioXCell
| Functional assays, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
BE0237-50MG
| InVivoMAb anti-mouse IL-18
| 50 mg
| BioXCell
| in vivo IL-18 neutralization, in vitro IL-18 neutr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0293-25MG
| InVivoMAb anti-mouse c-Kit (CD117)
| 25 mg
| BioXCell
| in vivo mast cell depletion, in vivo c-Kit+ cell d
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0211-25MG
| InVivoMAb anti-human CD1a
| 25 mg
| BioXCell
| in vitro CD1a blockade, Flow cytometry
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0276-1MG
| InVivoMAb anti-human/monkey CD20
| 1 mg
| BioXCell
| in vivo B cell depletion in hCD20 Tg mice, Immunoh
|
| Mouse
| Human, Monkey
| Solicitar Precio
| Solicitar
|
BE0237-1MG
| InVivoMAb anti-mouse IL-18
| 1 mg
| BioXCell
| in vivo IL-18 neutralization, in vitro IL-18 neutr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0239-5MG
| InVivoMAb anti-mouse 4-1BB (CD137)
| 5 mg
| BioXCell
| in vivo 4-1BB stimulation, in vitro 4-1BB stimulat
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0228-50MG
| InVivoMAb anti-mouse MHC Class I (H-2Kk, H-2Dk)
| 50 mg
| BioXCell
| Functional assays, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
BE0223-25MG
| InVivoMAb anti-mouse CD8? (Lyt 3.2)
| 25 mg
| BioXCell
| in vivo CD8+ T cell depletion, in vitro CD8 blocka
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0297-1MG
| InVivoMAb human IgG1 isotype control
| 1 mg
| BioXCell
|
|
| Human
|
| Solicitar Precio
| Solicitar
|
BE0196-1MG
| InVivoMAb anti-mouse BTLA (CD272)
| 1 mg
| BioXCell
| in vivo BTLA blockade, in vitro T cell stimulation
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
BE0288-1MG
| InVivoMAb anti-human CD4
| 1 mg
| BioXCell
| in vitro CD4 blockade, in vitro blocking of CD4+ T
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0198-1MG
| InVivoMAb anti-mouse/human IL-5
| 1 mg
| BioXCell
| in vivo IL-5 neutralization, in vivo eosinophil de
|
| Rat
| Human, Mouse
| Solicitar Precio
| Solicitar
|
BE0243-50MG
| InVivoMAb anti-mouse IL-1?
| 50 mg
| BioXCell
| in vivo IL-1? neutralization, in vitro IL-1? neutr
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
BE0193-1MG
| InVivoMAb anti-human PD-1 (CD279)
| 1 mg
| BioXCell
| in vivo PD-1 blockade in humanized mice, Flow cyto
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0206-25MG
| InVivoMAb anti-mouse F4/80
| 25 mg
| BioXCell
| in vivo Monocyte/Macrophage depletion, Functional
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0288-100MG
| InVivoMAb anti-human CD4
| 100 mg
| BioXCell
| in vitro CD4 blockade, in vitro blocking of CD4+ T
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0234-25MG
| InVivoMAb anti-human IL-12 p70
| 25 mg
| BioXCell
| Functional assays, ELISA, Flow cytometry
|
| Rat
| Human
| Solicitar Precio
| Solicitar
|
BE0220-50MG
| InVivoMAb anti-mouse CD209b (SIGN-R1)
| 50 mg
| BioXCell
| in vivo SIGN-R1 blockade, Immunohistochemistry (fr
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
BE0204-25MG
| InVivoMAb anti-mouse CSF1
| 25 mg
| BioXCell
| in vivo CSF1 neutralization
|
| Rat
|
| Solicitar Precio
| Solicitar
|
BE0260-50MG
| InVivoMAb Armenian hamster IgG isotype control, anti-glutathione S-transferase
| 50 mg
| BioXCell
|
|
| Armenian Hamster
|
| Solicitar Precio
| Solicitar
|
BE0270-1MG
| InVivoMAb anti-mouse CD47 (IAP)
| 1 mg
| BioXCell
| in vivo CD47 blockade, in vitro CD47 blockade, Imm
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0231-25MG
| InVivoMAb anti-human CD3
| 25 mg
| BioXCell
| in vivo T cell depletion in humanized mice, ex viv
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0232-25MG
| InVivoMAb anti-mouse CD29
| 25 mg
| BioXCell
| in vitro CD29 neutralization, Immunofluorescence,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0231-1MG
| InVivoMAb anti-human CD3
| 1 mg
| BioXCell
| in vivo T cell depletion in humanized mice, ex viv
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|